Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Total	Cardiac RMS LLC	Ambulnz FMC NA	Healthwrox	Common Stock	Common Stock Cardiac RMS LLC	Common Stock Ambulnz FMC NA	Additional Paid-in- Capital	Additional Paid-in- Capital Cardiac RMS LLC	Additional Paid-in- Capital Ambulnz FMC NA	Accumulated Deficit	Accumulated Deficit Ambulnz FMC NA	Accumulated Other Comprehensive Loss	Noncontrolling Interests	Noncontrolling Interests Ambulnz FMC NA	Noncontrolling Interests Healthwrox
Balance (in shares) at Dec. 31, 2021					100,133,953
Balance at Dec. 31, 2021	$ 227,057,024				$ 10,013			$ 283,161,216			$ (63,556,714)		$ (32,501)	$ 7,475,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)					195,152
Exercise of stock options	374,344				$ 195			374,149
Stock based compensation	1,422,937							1,422,937
Equity cost	(19,570)							(19,570)
Noncontrolling interest contribution	2,063,000													2,063,000
Net income (loss) attributable to noncontrolling interests	(1,257,257)													(1,257,257)
Foreign currency translation	(5,863)												(5,863)
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	10,629,694										10,629,694
Balance at Mar. 31, 2022	240,264,309				$ 10,208			284,938,732			(52,927,020)		(38,364)	8,280,753
Balance (in shares) at Mar. 31, 2022					100,329,105
Balance (in shares) at Dec. 31, 2021					100,133,953
Balance at Dec. 31, 2021	227,057,024				$ 10,013			283,161,216			(63,556,714)		(32,501)	7,475,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ambulnz Health liquidation	0
Net income (loss) attributable to noncontrolling interests	(2,237,048)
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	23,365,347
Balance at Jun. 30, 2022	254,393,696				$ 10,564			287,301,467			(40,191,367)		(27,930)	7,300,962
Balance (in shares) at Jun. 30, 2022					100,685,290
Balance (in shares) at Mar. 31, 2022					100,329,105
Balance at Mar. 31, 2022	240,264,309				$ 10,208			284,938,732			(52,927,020)		(38,364)	8,280,753
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)					417,927
Exercise of stock options	779,066				$ 418			778,648
Stock based compensation	1,999,619							1,999,619
Common stock repurchased (in shares)					(70,000)
Common stock repurchased	(497,899)				$ (70)			(497,829)
UK Ltd. Restricted Stock (in shares)					8,258
UK Ltd. restricted stock (Note 4)	82,305				$ 8			82,297
Net income (loss) attributable to noncontrolling interests	(979,791)													(979,791)
Foreign currency translation	10,434												10,434
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	12,735,653										12,735,653
Balance at Jun. 30, 2022	254,393,696				$ 10,564			287,301,467			(40,191,367)		(27,930)	7,300,962
Balance (in shares) at Jun. 30, 2022					100,685,290
Balance (in shares) at Dec. 31, 2022					102,411,162
Balance at Dec. 31, 2022	278,927,391				$ 10,241			301,451,435			(28,972,216)		741,206	5,696,725
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)					96,101
Exercise of stock options	249,715				$ 10			249,705
Stock bases compensation (in shares)					424,911
Stock based compensation	8,181,591				$ 42			8,181,549
UK Ltd. restricted stock (Note 4)	167,175							167,175
Ambulnz Health liquidation	70,284										70,284
Net income (loss) attributable to noncontrolling interests	(453,120)													(453,120)
Foreign currency translation	243,658												243,658
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	(3,465,670)										(3,465,670)
Balance at Mar. 31, 2023	283,921,024				$ 10,293			310,049,864			(32,367,602)		984,864	5,243,605
Balance (in shares) at Mar. 31, 2023					102,932,174
Balance (in shares) at Dec. 31, 2022					102,411,162
Balance at Dec. 31, 2022	278,927,391				$ 10,241			301,451,435			(28,972,216)		741,206	5,696,725
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Ambulnz Health liquidation	(70,284)
Net income (loss) attributable to noncontrolling interests	2,901,766
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	(5,476,937)
Balance at Jun. 30, 2023	283,860,579				$ 10,376			312,101,281			(33,729,702)		1,390,642	4,087,982
Balance (in shares) at Jun. 30, 2023					103,762,092
Balance (in shares) at Mar. 31, 2023					102,932,174
Balance at Mar. 31, 2023	283,921,024				$ 10,293			310,049,864			(32,367,602)		984,864	5,243,605
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)					260,410
Exercise of stock options	706,405				$ 26			706,379
Acquisition of entities (in shares)						117,330	360,145
Acquisition of entities, amount		$ 1,000,012				$ 12	$ 36		$ 1,000,000	$ (1,432,963)		$ 649,167
Purchase of interests			$ (3,997,716)	$ (1,296,553)											$ (3,213,956)	$ (1,296,553)
Stock bases compensation (in shares)					92,033
Stock based compensation	1,778,010				$ 9			1,778,001
Net income (loss) attributable to noncontrolling interests	3,354,886													3,354,886
Foreign currency translation	405,778												405,778
Net income attributable to stockholders of DocGo Inc. and Subsidiaries	(2,011,267)										(2,011,267)
Balance at Jun. 30, 2023	$ 283,860,579				$ 10,376			$ 312,101,281			$ (33,729,702)		$ 1,390,642	$ 4,087,982
Balance (in shares) at Jun. 30, 2023					103,762,092